United States · FDA National Drug Code directory
Jemperli
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0173-0898_da2ad681-d178-42c9-aa55-47c619cc7cb1
- Product NDC
- 0173-0898
- Form
- INJECTION
- Composition / generic term
- dostarlimab
- Labeler
- GlaxoSmithKline LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210422
- Source listing expiry
- 20271231
Source-listed ingredients
- DOSTARLIMAB — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0173-0898-03) / 10 mL in 1 VIAL · 0173-0898-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →